| scholarly article | Q13442814 |
| P50 | author | Donna Niedzwiecki | Q94375040 |
| Eileen M. O'Reilly | Q57517885 | ||
| Federico Innocenti | Q87833394 | ||
| P2093 | author name string | Chen Jiang | |
| Alan P Venook | |||
| Kouros Owzar | |||
| Mary F Mulcahy | |||
| Alliance for Clinical Trials in Oncology | |||
| Charles Fuchs | |||
| Hedy L Kindler | |||
| Katherine Van Loon | |||
| P2860 | cites work | Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review | Q22305894 |
| A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 | Q28943270 | ||
| Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase | Q31831783 | ||
| Vitamin D: newly discovered actions require reconsideration of physiologic requirements | Q33530770 | ||
| Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes | Q33997476 | ||
| Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). | Q34049260 | ||
| Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. | Q34246571 | ||
| Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer | Q34577228 | ||
| Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. | Q34866290 | ||
| Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. | Q34967426 | ||
| Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans | Q36187658 | ||
| Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro | Q36431217 | ||
| Racial disparities in gastrointestinal cancers-related mortality in the U.S. population | Q36784183 | ||
| Vitamin D status: measurement, interpretation, and clinical application | Q37105927 | ||
| High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy | Q37171282 | ||
| Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. | Q39606361 | ||
| Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells | Q39994375 | ||
| Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells | Q40341429 | ||
| Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. | Q40540529 | ||
| Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3. | Q40595941 | ||
| Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D(3) among MCF-7 clones correlates with Vitamin D receptor protein induction | Q40715887 | ||
| Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro | Q41823940 | ||
| Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. | Q42859934 | ||
| An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation | Q43937979 | ||
| Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer | Q44136002 | ||
| Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number | Q44370565 | ||
| Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines | Q45129538 | ||
| Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles | Q46147113 | ||
| An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. | Q53059060 | ||
| Hypovitaminosis D in Medical Inpatients | Q57414040 | ||
| Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines | Q71035995 | ||
| Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer | Q80568407 | ||
| A multiple testing procedure to associate gene expression levels with survival | Q81273877 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P577 | publication date | 2014-08-06 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). | |
| P478 | volume | 106 |
| Q92620116 | A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers |
| Q86181816 | Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3 |
| Q36279579 | Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer |
| Q57479955 | Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival |
| Q33845341 | Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation |
| Q94562389 | Pancreatic cancer stroma: an update on therapeutic targeting strategies |
| Q42362792 | Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis |
| Q64999022 | Possible role of vitamin D3 on the adipocyte/fibroblast trans-differentiation mediated by pancreas cancer |
| Q37234780 | Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q36574978 | Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer |
| Q53636755 | Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China. |
| Q33577607 | The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis |
| Q58783408 | The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation |
Search more.